EUVIMEDEUVIMED entdecken
Open Access

Lung cancer chemo-interception by sulfasalazine and disulfiram codelivered using a nano self-emulsifying drug delivery system in mice

Fekadu Kassie iD, Kevin Wang iD, Katherine Bang iD, Mohammed Riaz Hasan Chowdhury iD, Jeffrey Wang iD, Sunil Prabhu iD, Xueqing Liang iD, Davis Seelig iD, Preshita Desai iD

Carcinogenesis · 21.11.2025 · 46 (4)

DOI: 10.1093/carcin/bgaf075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis, online erschienen am 28.10.2025. Verfasst von Fekadu Kassie und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108, United States. Hauptthemen laut MEDLINE: Disulfiram, Sulfasalazine, Lung Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although preclinical studies consistently indicate that sulfasalazine (SAS) and disulfiram (DSF) are promising agents for the prevention and treatment of lung cancer, their clinical efficacy is limited. This discrepancy is attributed to the poor bioavailability of the drugs. Therefore, in the present study, we explored whether delivery of lower doses of SAS and DSF in nano self-emulsifying drug delivery systems (Nano-SEDDS) improves their potency and efficacy in suppressing malignant progression of lung tumors. Mice were treated with the tobacco smoke carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and once lung adenoma developed, high doses of free SAS (250 mg/kg) + DSF (100 mg/kg) or SEDDS formulations containing lower doses of SAS + DSF (40 mg/kg SAS + 8, 16 or 40 mg/kg DSF) were administered by oral gavage, every other day, for 10 weeks. Although the doses of SAS and DSF contained in SAS + DSF-SEDDS were about 6-fold and 3–15-fold lower, respectively, than the doses of the respective free drugs, SAS + DSF-SEDDS was more effective than free SAS + DSF in reducing the multiplicity of bigger lung tumors (≥1 mm). These effects were paralleled by significant reductions in the multiplicity of adenoma with progression and adenocarcinoma histopathological lesions. Also, lung tumors from mice treated with SAS + DSF-SEDDS exhibited an increase in the level of 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA), lipid peroxidation products. Overall, our results show that the Nano-SEDDS formulation of SAS + DSF is a promising approach to enhance the potency and efficacy of the drugs for lung cancer chemo-interception and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DisulfiramSulfasalazineLung NeoplasmsDrug Delivery SystemsAnimalsMiceEmulsionsNitrosaminesMaleAdenoma

Stichwörter der Autor:innen

4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)disulfiramlung tumorself-emulsifying drug delivery systemssulfasalazine

Substanzen

DisulfiramSulfasalazineEmulsionsNitrosamines4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone

Autor:innen und Institutionen

  • College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108, United States.
  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States.
  • Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA 92697, United States.
  • Department of Biotechnology and Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, United States.

ORCID-Profile: Fekadu Kassie, Kevin Wang, Katherine Bang, Mohammed Riaz Hasan Chowdhury, Jeffrey Wang, Sunil Prabhu, Xueqing Liang, Davis Seelig, Preshita Desai

Förderung

  • NCI NIH HHS
  • NIH
  • NCI
  • National Institute of Health

Zitieren

APA

Kassie, F., Wang, K., Bang, K., Chowdhury, M. R. H., Wang, J., Prabhu, S., Liang, X., Seelig, D., & Desai, P. (2025). Lung cancer chemo-interception by sulfasalazine and disulfiram codelivered using a nano self-emulsifying drug delivery system in mice. Carcinogenesis, 46(4). https://doi.org/10.1093/carcin/bgaf075

Vancouver

Kassie F, Wang K, Bang K, Chowdhury MRH, Wang J, Prabhu S, et al. Lung cancer chemo-interception by sulfasalazine and disulfiram codelivered using a nano self-emulsifying drug delivery system in mice. Carcinogenesis. 2025;46(4). doi:10.1093/carcin/bgaf075

BibTeX
@article{Kassie2025,
  author = {Kassie, Fekadu and Wang, Kevin and Bang, Katherine and Chowdhury, Mohammed Riaz Hasan and Wang, Jeffrey and Prabhu, Sunil and Liang, Xueqing and Seelig, Davis and Desai, Preshita},
  title = {Lung cancer chemo-interception by sulfasalazine and disulfiram codelivered using a nano self-emulsifying drug delivery system in mice},
  journal = {Carcinogenesis},
  year = {2025},
  volume = {46},
  number = {4},
  doi = {10.1093/carcin/bgaf075}
}
Kostenlos starten →